Massive Bio
About Massive Bio
Massive Bio is a digital health company that leverages artificial intelligence (AI) to revolutionize oncology clinical trial matching and patient access to advanced cancer treatments. Their mission is to ensure every cancer patient can access clinical trials, irrespective of their geographical location or financial status. The company’s proprietary AI platform, including tools like SYNERGY-AI and Deep Learning Clinical Trial Matching System (DLCTMS), meticulously analyzes comprehensive patient data—such as diagnosis, disease stage, genomic profiles, biomarkers, and treatment history. This enables precise matching of patients to a vast global database of actively recruiting clinical trials, which can exceed 19,000 studies.
For physicians, Massive Bio offers an invaluable resource to streamline the complex process of clinical trial referrals. Their “Trial Relay” platform is designed to save physicians time and enhance patient outcomes by providing AI-powered matching capabilities. Crucially, all AI-generated matches undergo validation by Massive Bio’s team of physicians, ensuring a blend of technological innovation with expert clinical oversight. The company fosters extensive collaborations with leading pharmaceutical companies, global partners, and patient advocacy groups, operating in numerous countries and languages to broaden the reach of advanced cancer clinical trials. Beyond matching, Massive Bio provides comprehensive concierge services, guiding patients through eligibility assessments, financial considerations, and appointment scheduling, thereby alleviating significant burdens on both patients and their treating oncologists.
Focus Areas
Business Intelligence
| Key Investors | Revo Capital, Cavendish Impact Foundation (CIF), DEG – Deutsche Investitions- und Entwicklungsgesellschaft mbH, Kenan Turnacıoğlu PaigeAI, Schusterman Family Investments, International Finance (Washington D.C.) |
| Partnerships | TheSocialMedwork, Flatiron Health, American Cancer Society (ACS ACTS), Foundation Medicine, Un Ensayo Para Mi (UEPM), Precision Cancer Consortium (PCC) |
| Technology | SYNERGY-AI/DLCTMS (Deep Learning Clinical Trial Matching System), Natural Language Processing (NLP), Computer Vision, Large Language Model (LLM) and Generative Pre-trained Text (GPT) for Dr Arturo AI (for physicians) and Ask Fiona AI (for patients), Reticulum Nexus (multi-agent platform) |
What Physicians Need to Know
Massive Bio's platform, particularly 'Trial Relay' and 'Dr. Arturo AI,' is designed to significantly reduce the administrative burden of finding and referring patients to clinical trials. Physicians can securely submit patient information online, receive AI-generated clinical summaries and tailored trial matches, and even identify trials recruiting at their own institution. The integrated concierge services for patients further free up physician time, ensuring patients receive comprehensive support throughout their trial journey. Leveraging their real-world data and AI-driven insights can also aid in more informed, data-driven treatment decisions and provide access to the latest therapeutic options. The platform is HIPAA-compliant, ensuring patient data privacy.
Massive Bio's SYNERGY-AI platform is built to function as clinical infrastructure, embedded within oncology workflows. It processes information from electronic health records (EHRs) and integrates with various stakeholders in the pharmaceutical value chain, including drug developers, hospitals, and genomic companies. They also partner with health tech companies like Flatiron Health to enhance patient identification and leverage robust data harmonization frameworks with partners like Prognos Health for enhanced real-world data and insights. The system is designed for real-time, actionable intervention at the point of care.
Reviews & Opinions
Videos
News, demos, and interviews about Massive Bio.
Videos load interactively. If none appear, search YouTube for Massive Bio →
Press & Coverage
Frequently Asked Questions
Investors
Who's funded Massive Bio.
Related Companies
QuickIntell is an AI-first healthcare technology company dedicated to transforming healthcare operations for physicians and healthcare providers. The company leverages advanced AI agents, including Computer Vision, Machine Learning, Optical Character Recognition (OCR), and Natural Language Processing (NLP), to streamline administrative workflows and enhance Revenue Cycle Management (RCM). QuickIntell’s solutions are designed to reduce administrative burden, […]
Ease Tax Relief, founded in 2016, is a tax relief and resolution company based in Harleysville, PA. The company specializes in helping individuals and small businesses resolve issues with the IRS, offering services such as Offer in Compromise, Partial Pay Installment Agreements, Payment Plans, and Penalty Reduction. Owned and operated by Zheng Yang, a CPA […]
CAIMed, the Lower Saxony Center for Artificial Intelligence and Causal Methods in Medicine, is a research institution dedicated to advancing personalized healthcare through innovative AI and causal methodologies. The center aims to address widespread diseases such as cancer, cardiovascular diseases, and infections by linking research data, clinical data, and patient care data. This integrated approach, […]
Autoderm is a health technology company that provides a CE-marked AI dermatology screening API designed to analyze smartphone photos for various skin conditions. The company’s AI models are trained on a proprietary database of amateur smartphone images of skin diseases and are accessible via an API that can be integrated into various platforms, including electronic […]
OCTA is an AI-powered finance automation platform that aims to streamline financial operations and accelerate cash flow for businesses, particularly SMEs and enterprises in the Middle East, with a strong presence in the UAE and Saudi Arabia. The platform utilizes AI agents to automate tasks across the entire contract-to-cash cycle, including contract creation, e-signing, invoicing, […]
Skin Analytics is a British health technology company dedicated to the early and accurate diagnosis of skin cancer, aiming to reduce mortality from the disease. They achieve this through their flagship product, DERM, an AI-powered medical device. DERM is designed to provide dermatologist-quality skin cancer assessments, making them more accessible and reducing the burden on […]